Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293703 · ClinicalTrials.gov registry record · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
A NA study of Morbid Obesity, sponsored by Salvador Navarrete.
- Recruiting
- Registry status
- NA
- Development phase
- 262
- Enrollment target
- 1
- Study location
NCT06293703: Recruiting NA study of Morbid Obesity, sponsored by Salvador Navarrete.
NCT06293703 is a NA study of Morbid Obesity that is actively recruiting participants, run by Salvador Navarrete. The registered enrollment target is 262 participants, above the 111-participant average among 24 other Morbid Obesity trials with a reported enrollment target (136% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06293703, a NA study of Morbid Obesity, is actively recruiting participants, sponsored by Salvador Navarrete.
- RECRUITING
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of standardizing RYGB limb lengths and optimizing resultant weight loss and metabolic effects. The investigators hypothesize RYGB with ratio-adjusted limb lengths (aRYGB) will result in higher total weight loss and resolution of metabolic syndrome comorbidities, including diabetes, hyperlipidemia, and hypertension compared to standard fixed-length RYGB (sRYGB). The study will also utilize the Short Form Rand 36-Item Health Survey (SF36) to determine differences in postoperative quality of life metrics.
Primary Outcome
Measured in kilograms
Conditions Studied
Interventions
- PROCEDURE Surgery
Study Locations (1)
Ohio
- Cleveland clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2024-01-12 |
| Est. Completion | 2030-12-11 |
| Phase | NA |
What NCT06293703 shows while recruiting
NCT06293703 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, above the 111-participant average among 24 other Morbid Obesity trials with a reported enrollment target (136% higher).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Surgery is the first listed.
NCT06293703 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06293703 about?
NCT06293703 is a clinical study titled "Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)". The investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of standardizing RYGB l...
What is the current status of trial NCT06293703?
This trial is currently recruiting. It is a NA study. The enrollment target is 262 participants. The study started on 2024-01-12. Estimated completion is 2030-12-11.
What conditions does trial NCT06293703 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT06293703?
The interventions under investigation include: Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06293703?
This trial is sponsored by Salvador Navarrete, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06293703 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06293703's enrollment target sits among peer trials
262 3rd of 24 higher than 22 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Activity Level Monitoring Study
ACTIVE NOT RECRUITING · NA
-
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates
COMPLETED · NA
-
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
COMPLETED · NA
-
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
COMPLETED · NA
-
Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
COMPLETED · NA
-
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI